Sdc Clinical (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 32.53%
(FY 2023)
- Profit 36.63%
(FY 2023)
- Ebitda 27.22%
(FY 2023)
- Net Worth 85.62%
(FY 2023)
- Total Assets 72.28%
(FY 2023)
About Sdc Clinical (India)
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kannan Sankaranarayanan and Richard Abelson serve as directors at the Company.
- CIN/LLPIN
U73200TG2020FTC140171
- Company No.
140171
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
23 Apr 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sdc Clinical (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Richard Abelson  | Director | 23-Apr-2020 | Current |
Kannan Sankaranarayanan  | Director | 08-Sep-2020 | Current |
Financial Performance of Sdc Clinical (India).
Sdc Clinical (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.53% increase. The company also saw a substantial improvement in profitability, with a 36.63% increase in profit. The company's net worth Soared by an impressive increase of 85.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sdc Clinical (India)?
In 2023, Sdc Clinical (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vistra Corporate Services (India) Private LimitedActive 29 years 8 monthsKannan Sankaranarayanan is a mutual person
Datacore Software India Private LimitedActive 5 years 1 monthKannan Sankaranarayanan is a mutual person
Medforth Support Services India LlpActive 5 years 11 monthsKannan Sankaranarayanan is a mutual person
- Equipped Analytical Intelligence (India) LlpActive 5 years 5 months
Kannan Sankaranarayanan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sdc Clinical (India)?
Sdc Clinical (India) has a workforce of 51 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sdc Clinical (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sdc Clinical (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
